Inhibition of dopamine and choline acetyltransferase concentrations in Rat CNS neurons by rat α1- and α2-macroglobulins

Journal of Neuroscience Research

Volumn 51, Issue 4, 1998, Pages 541-550

  Hu, Yi Qun ^a   Liebl, Daniel J ^a   Dluzen, Dean E ^a   Koo, Peter H ^a  

^a Northeastern Ohio Medical University   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Monoamines; Neurotransmitter; Neurotrophin; Nigrostriatum; Parkinson's disease

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 MACROGLOBULIN; ALPHA 2 MACROGLOBULIN; CHOLINE ACETYLTRANSFERASE; DOPAMINE; MACROGLOBULIN; MONOAMINE; NEUROTRANSMITTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FOREBRAIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-MACROGLOBULINS; ANIMALS; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; ENZYME ACTIVATION; INJECTIONS, INTRAVENTRICULAR; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STEREOTAXIC TECHNIQUES;

EID: 0032519966     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980215)51:4<541::AID-JNR14>3.0.CO;2-6     Document Type: Article

References (53)

1. 1-antichymotrypsin in brain dysfunction and injury. Res Immunol 143:631-636.
2. Bank RE, Evans SW, Alexander D, Van Leuven F, Whicher JT, McMahon MJ (1991): Alpha-2-macroglobulin state in acute pancreatitis. Raised values of alpha-2-macroglobulin-protease complexes in severe and mild attacks. Gut 32:430-434.
3. Bank RE, Evans SW, Van Leuven F, Alexander D, McMahon MJ, Whicher JT (1990): Measurement of the "fast" or complexed form of alpha-2-macroglobulin in biological fluids using a sandwich enzyme immunoassay. J Immunol Methods 126:13-20.
4. Barrett AJ, Brown MA, Sayers CA (1979): The electrophoretically "slow" and "fast" forms of the alpha-2-macroglobulin molecule. Biochem J 181:401-418.
5. Bauer J, Ganter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M (1992): The participation of IL-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143:650-657.
6. Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Volk B, Berger M (1991): Interleukin-6 and α-2-macroglobulin indicate an acute-phase slate in Alzheimer's disease cortices. FEBS Lett 285:111-114.
7. Bu G, Masksymovitch EA, Nerbonne JM, Schwartz AL (1994): Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269:18521-18528.
8. Campell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L (1993): Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061-5.
9. 2-macroglobulin, an acute phase protein in the brain. J Neurosci Res 43:282-288.
10. 1-macroglobulin, a broad-range proteinase inhibitor from the α-macroglobulin-complement family. Mol Biol Med 8:287-302.
11. - sion in human astrocytoma cells. J Neuroimmunol 53:31-37.
12. Fonnum F (1975): A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409.
13. 2-macroglobulin homologue: Interaction with plasmin and trypsin. Biochim Biophys Acta 322:62-67.
14. Garton MJ, Keir G, Lakshmi MV, Thompson EJ (1991): Age-related changes in cerebrospinal fluid protein concentrations. J Neurol Science 104:74-80.
15. Ganter U, Strauss S, Jonas L, Weidemann A, Beyreuther K, Volk B, Berger M, Bauer J (1991): Alpha-2-macroglobulin synthesis in interleukin-6-stimulated human neuronal(SH-SY5Y neuroblastoma) cells. FEBS Lett 282:127-131.
16. Giometto B, Argentiero V, Sanson F, Ongaro G, Tavolato B (1988): Acute phase proteins in Alzheimer's disease. Eur Neurol 28:30-33.
17. 2-macroglobulins of rat serum. Biochem J 159:643-650.
18. 2-macroglobulin-encoding gene in rat brain and cultured astrocytes. Gene 141:155-162.
19. Hirota H, Kiyama H, Kishimoto T, Taga T (1996): Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL)-6 and IL-6 receptor after trauma. J Exp Med 183:2627-34.
20. Hocke GM, Cui MZ, Ripperger JA, Fey GH (1992): Regulation of the rat os-macroglobulin gene by interleukin-6 and leukemia inhibitory factor. Folia Histochemi Cytobiol 30:137-139.
21. Hu YQ (1997): The effect of alpha-2-macroglobulin on dopamine concentration in corpus striatum and trkB-mediated signal transduction and gene expression: A study on its potential role in neurodegeneration in the central nervous system. Ph.D. dissertation, The Kent State University/Northeastern Ohio Universities College of Medicine.
22. 2-macroglobulin decreases dopamine concentrations within the rat caudate putamen. J Neurosci Res 38:531-537.
23. 2-macroglobulin. J Neurosci Res 43:71-77.
24. 2-macroglobulin blocks signal transduction mediated by neurotrophic receptors, trk B and trkC. FASEB J 10:A1407.
25. 2-macroglobulin homologue. Biochim Biophys Acta 704:290-303.
26. 2-macroglobulin in human plasma: Development of a new enzyme linked in immunosorbent assay (ELISA) for quantisation of complexed α2-macroglobulin. Scand J Clin Lab Invest 53:639-648.
27. Kodelja V, Heisig M, Northemann W, Heinrich PC, Zimmermann W (1986): Alpha-2-macroglobulin gene expression during rat development studied by in situ hybridization. EMBOJ 5:3151-3156.
28. 2-macroglobulin respectively enhance, and inhibits trkA activation and sciatic nerve regeneration. Neuroimmunomodulation 3:186.
29. 2-macroglobulin. J Neurosci Res 31:678-692.
30. 2-macroglobulin inhibits neurite outgrowth, survival, choline acetyltransferase, and dopamine concentration of neurons by blocking neurotrophin-receptor (trk) phosphorylation and signal transduclion. Ann N Y Acad Sci 737:460-464.
31. 2-macroglobulin binds trk receptor and inhibits nerve growth factor-stimulated trk phosphorylation and signal transduction. J Biol Chem 269:5369-5376.
32. Koo PH, Stach RW (1989): Interaction of nerve growth factor with murine alpha-macroglobulin. J Neurosci Res 22:247-261.
33. 2-macroglobulin homologues. Ph.D. dissertation, Kent State University/Northeastern Ohio Universities College of Medicine.
34. 2-macroglobulin inhibits neurite outgrowth and survival of embryonic sensory and cerebral cortical neurons. J Neurosci Res 35:170-182.
35. Liebl DJ, Koo PH (1993b): Comparative binding of neurotrophins (NT-3, CNTF and NGF) and various cytokines to alpha-2-macroglobulin. Biochem Biophys Res Commun 193:1255-1261.
36. 2-macroglobulin inhibits choline acetyltransferase of embryonic basal forebrain neurons and reversal of the inhibition by NGF and BDNF but not NT-3. J Neurosci Res 38:407-414.
37. Lonberg-Holm K, Reed DL, Roberts RC, Damato-McCabe D (1987a): Three high-molecular-weight protease inhibitors of rat plasma. Reactions with trypsin. J Biol Chem 262:4844-4853.
38. Lonberg-Holm K, Reed DL, Roberts RC, Hebert RR, Hillman MC, Kutney RM (1987b): Three high-molecular-weight protease inhibitors of rat plasma: Isolation, characterization, and acute phase changes. J Biol Chem 262:438-445.
39. Lowery OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with folin phenol reagent. J Biol Chem 193:265-275.
40. Matsuda S, Saito H, Nishiyama N (1990): Basic fibroblast growth factor suppressed the enhancement of choline acetyltransferase activity induced by nerve growth factor. Neurosci Lett 114:69-74.
41. 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375-82.
42. Morrison RS, Sharma A, De Vellis J, Bradshaw RA (1986): Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc Natl Acad Sci USA 83:7537-7541.
43. 2-macroglobulin. J Biol Chem 260:15723-15735.
44. 2-macroglobulins. Biochem Biophys Res Commun 108:1-7.
45. Sottrup-Jensen L, Petersen TE, Magnusson S (1981): Trypsin-induced activation of the thiolesters in alpha-2-macroglobulin generates a short-lived intermediate ("Nascent" alpha-2-M) that can react rapidly to incorporate not only methylamine or putrescine but also proteins lacking proteinase activity. FEBS Lett 128:123-126.
46. Stewart WF, Kawas C, Corrada M, Metter EJ (1997): Risk of Alzheimer's disease and duration of NSAID use. Neurology 48:626-632.
47. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66:223-230.
48. Swenson R, Howard JB (1979): Structural characterization of human oii-macroglobulin. J Biol Chem 254:4452-4456.
49. Van Gool D, DE Strooper B, Van Leuven F, Triau E, Dom R (1993): Alpha-2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiol Aging 14:233-237.
50. Walicke PA, Cowan WM, Ueno N, Baird A, Guillemin R (1986): Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA 83:3012-3016.
51. Willis GL (1987): Amine accumulation in Parkinson's disease and other disorders. Neurosci Biobehav Rev 11:97-105.
52. 2-macroglobulin under apparent equilibrium conditions. Biochemistry 33:11270-11277.
53. Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R (1993): Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1-beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha-2-macroglobulin and C-reactive protein. Brain Res 629:245-252.